HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: WHAT PREDICTS THE OUTCOME?

被引：0
|
作者：
Kumar, L. [1 ]
Ganess, P. [1 ]
Gogia, A. [1 ]
Ghosh, I. [1 ]
Hariprasad, R. [1 ]
机构：
[1] All India Inst Med Sci, Delhi, India
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
220
引用
收藏
页码：S239 / S240
页数：2
相关论文
共 50 条
  • [31] HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: ACHIEVEMENT OF COMPLETE REMISSION IS ASSOCIATED WITH IMPROVED SURVIVAL
    Kumar, L.
    Ghosh, J.
    Ganessan, P.
    Gupta, A.
    Hariprasad, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 69 - 69
  • [32] High dose sequential chemotherapy and autologous peripheral stem cell transplantation in patients with previously treated or untreated multiple myeloma
    Kuhlmann, S
    Fossa, A
    Wrzeciono, T
    Kasper, C
    Welt, A
    Seeber, S
    Nowrousian, MR
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 352 - 353
  • [33] Results of high dose chemotherapy and autologous stem cell transplantation in patients with chemo-responsive multiple myeloma.
    Ault, KA
    Case, DC
    Boyd, MA
    Ervin, TJ
    Aronson, FR
    Ebrahim, KS
    Hedlund, JA
    BLOOD, 2002, 100 (11) : 470B - 470B
  • [34] Cellular immune function in multiple myeloma patients after high dose chemotherapy and autologous peripheral stem cell transplantation
    Lindemann, M
    Schütt, P
    Moritz, T
    Nowrousian, MR
    Grosse-Wilde, H
    GENES AND IMMUNITY, 2003, 4 : S46 - S46
  • [35] Results of high dose chemotherapy and autologous stem cell transplantation in patients with chemo-responsive multiple myeloma.
    Ault, KA
    Case, DC
    Boyd, MA
    Ervin, TJ
    Aronson, FR
    Ebrahim, KS
    Hedlund, JA
    BLOOD, 2003, 102 (11) : 481B - 482B
  • [36] The Role of High Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients with Multiple, Myeloma Refractory to Initial Induction Therapy
    Parrish, Christopher
    Rahemtulla, Amin
    Cavet, James
    Pearce, Rachel
    Keiran, Kirkland
    Lee, Julia
    Craddock, Charles
    Wilson, Keith
    Cook, Gordon
    BLOOD, 2010, 116 (21) : 574 - 575
  • [37] Results of high dose chemotherapy and autologous stem cell transplantation in patients with chemo-responsive multiple myeloma.
    Ault, KA
    Case, DC
    Boyd, MA
    Thomas, EJ
    Frederick, AR
    Kurt, ES
    Jaquelyn, HA
    BLOOD, 2005, 106 (11) : 454B - 455B
  • [38] Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation
    Vogel, W
    Kopp, HG
    Kanz, L
    Einsele, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) : 214 - 218
  • [39] Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation
    Wichard Vogel
    Hans-Georg Kopp
    Lothar Kanz
    Hermann Einsele
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 214 - 218
  • [40] Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
    Srour, Samer A.
    Milton, Denai R.
    Bashir, Qaiser
    Nieto, Yago
    Saini, Neeraj
    Daher, May
    Ramdial, Jeremy
    Im, Jin
    Hosing, Chitra
    Delgado, Ruby
    Manasanch, Elisabet
    Lee, Hans C.
    Thomas, Sheeba
    Kaufman, Gregory
    Patel, Krina
    Popat, Uday
    Weber, Donna
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    HAEMATOLOGICA, 2021, 106 (12) : 3211 - 3214
12345